Abstract. Advances in preclinical radiotherapy systems have provided the technical foundations for delivering highly heterogeneous dose distributions for unique radiobiological experiments, but methods to deliver arbitrary dose distributions are in their infancy. This study developed a method to optimize and automatically deliver planar dose distributions on a recently developed preclinical radiotherapy platform. The method was based on empirically determined dose kernel distributions from radiochromic film measurements. These kernels were used to determine optimal animal stage positions and beam weights to deliver a desired dose distribution at a given depth using a sequential quadratic programming optimization algorithm. The method was validated by end-to-end delivery of two dosimetric challenges designed to quantify targeting and dosimetric accuracy. The results revelead an overall targeting accuracy of 112 µm and a dosimetric delivery error, calculated along four line profiles in radiochromic film measurements, of 6.8%. Mean absolute delivery error across a linear dose gradient between 0 and 1 Gy over 7.5 mm was 0.03 Gy. These results confirm the optimization framework is an effective platform for delivery of millimetre scale heterogeneous dose distributions with sub-millimetre accuracy.
Introduction
Continual technological advances in clinical radiotherapy practice have conferred the ability to accurately and conformally modulate dose at millimetre scale resolutions. By and large, the sophisticated beam arrangements permitted by these advances were not validated on animal models, partially due to a corresponding innovation lag in preclinical radiotherapy tools. This gap has recently been mitigated by the introduction of preclinical radiotherapy systems which support sub-millimetre animal positioning setup based on fluoroscopic, cone-beam computed tomography (CBCT), or CT imaging with interchangeable or variable aperture collimated dose delivery at rates from 2-4 Gy/min [1, 2, 3] . A missing element for preclinical dose delivery is to exploit this ability to optimally deliver arbitrary dose distributions. The goal of this work was to develop a general framework for two-dimensional dose optimization on a recently developed preclinical irradiator [1] .
Methods
The overall method, illustrated in Figure 1 , was designed on the basis of empirically measured dose kernel primitives of the small animal radiotherapy system. Dose kernel measurements were made in a 95 × 45 mm solid water phantom at a depth of 10 mm with 29 mm of backscatter. The irradiation isocenter was set under CBCT guidance (to mimic a common small animal setup protocol) to a depth of 10 mm. Phantom and films were irradiated using a 1 mm circular collimator for 60 s at a tube output of 225 kVp / 13 mA. This dose kernel primitive, together with an arbitrary desired dose distribution, were used in a sequential quadratic programming optimization method [4] to define a set of beam positions and weights to minimize the difference between the desired and delivered doses. The initial beam positions were defined in a hexagonal arrangement based on maximizing density in a circle packing arrangement [5] . Initial beam weights were defined, for each beam, to deliver the mean of the dose within the half maximum area of that beam. These beam positions and weights were used as the initial conditions in the optimization method. Denoting the desired two-dimensional dose by D d , the optimization problem sought to minimize
where D c (p, ω) is the calculated dose for beam positions p and weights ω, and the norm is calculated across all pixels of the dose error. Dose was calculated based on a convolution of the beam positions, multiplied by their respective weights, with the dose kernel. Optimized beam positions were converted to stage positions using an in-house developed program which automated dose delivery by iterating through the set of stage positions, pausing at each position according to the beam weight of the respective beam. End-to-end efficacy of the proposed approach was quantified for two desired dose distributions designed to test the overall targeting and dosimetric accuracy. The first distribution, shown in the top left panel of Figure 2 , was a bullseye pattern consisting of 1 mm wide rings with the rings alternating between desired doses of 0 and 2 Gy. A 27 gauge (0.4 mm diameter) needle tip fiducial was embedded in the radiochromic film for the bullseye distribution to define the desired delivery isocenter and quantify targeting accuracy. The second distribution (top left panel of Figure 3 ) was a 'sock' pattern consisting of a 1 Gy region exponentially decaying 1.5 mm horizontally over 3 mm vertically (labelled A in the figure), a homogeneous constant 1 Gy 1.5 × 4 mm rectangular region (B), a linear dose gradient rectangle of 7.5 mm × 4 mm (C), and a 2 mm radius semicircle with constant 1 Gy dose (D). 
Results
The dosimetric results for the bullseye distribution are outlined in Figure 2 . The effects of the embedded fiducial marker have been removed by masking out a 5 mm radius circle at the center of the relevant distributions. Dose along the vertical and horizontal line profiles, illustrated in the desired dose distribution, are shown along the bottom row. Mean absolute dose differences between the delivered and desired distribution were 0.41 Gy and 0.38 Gy along the horizontal and vertical line profiles, respectively. Between the delivered and optimized distributions, the respective differences were 0.12 Gy for both line profiles. Targeting accuracy, assessed by the difference between the position of the embedded needle fiducial (denoting the desired delivery isocenter) and the actual delivered isocenter was 112 µm. The results of the sock dose delivery are illustrated in Figure 3 . As with the analysis of the bullseye distribution, the top row shows the desired, optimized, delivered, and difference (delivered minus optimized) dose distributions. The dose along four profiles, visually indicated in the desired dose profile, are shown along the bottom row. The mean absolute difference along the decaying exponential in panel A between the delivered and desired dose is 0.20 Gy and the dose falls below the desired 1 Gy for the last 1.9 mm of the 1 Gy region. The delivered dose of the linear gradient in panel C closely corresponds to the desired dose with a mean absolute difference of 0.03 Gy between 2.5 and 10 mm. Across all four panels, the mean absolute difference between the delivered and optimized doses is 0.04 Gy (relative difference of 6.8% for all profile portions greater than 0.05 Gy). The same difference between the delivered and desired doses is 0.11 Gy (relative difference of 13.0% for all profile portions greater than 0.05 Gy). 
Conclusions
The optimized preclinical treatment planning and delivery framework developed in this work provides delivery of arbitrary two-dimensional dose distributions to mm scale dosimetric and geometric constructs with a targeting accuracy of approximately 0.1 mm.
